Accumulation and toxicity of superparamagnetic iron oxide nanoparticles in cells and experimental animals

International Journal of Molecular Sciences

Volumn 17, Issue 8, 2016, Pages

  Jarockyte, Greta ^a   Daugelaite, Egle ^a   Stasys, Marius ^a   Statkute, Urte ^a   Poderys, Vilius ^a   Tseng, Ting Chen ^b   Hsu, Shan Hui ^b   Karabanovas, Vitalijus ^a,c   Rotomskis, Ricardas ^a,d  

^a NATIONAL CANCER INSTITUTE   (Lithuania)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c VILNIUS GEDIMINAS TECHNICAL UNIVERSITY   (Lithuania)

^d VILNIUS UNIVERSITY   (Lithuania)

Author keywords

Cellular uptake; Iron oxide; Magnetic nanoparticles; MRI optical dual imaging; Multifunctional cancer diagnostics; Optical biopsy of tissues cells; SPIONs

Indexed keywords

SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; CONTRAST MEDIUM; FERRIC ION; FERRIC OXIDE; METAL NANOPARTICLE;

ADULT; ANIMAL CELL; ARTICLE; CELL COUNTING; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACCUMULATION; DRUG SYNTHESIS; IMAGE ANALYSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTICLE SIZE; RAT; TOXICITY TESTING; X RAY POWDER DIFFRACTION; ZETA POTENTIAL; 3T3 CELL LINE; ANIMAL; ATOMIC FORCE MICROSCOPY; INTRAMUSCULAR DRUG ADMINISTRATION; METABOLISM; MOUSE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; WISTAR RAT;

ANIMALS; CONTRAST MEDIA; FERRIC COMPOUNDS; INJECTIONS, INTRAMUSCULAR; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; METAL NANOPARTICLES; MICE; MICROSCOPY, ATOMIC FORCE; NIH 3T3 CELLS; RATS; RATS, WISTAR;

EID: 84983568200     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms17081193     Document Type: Article

References (40)

1. Runge, V.M.; Clanton, J.A.; Lukehart, C.M.; Partain, C.L.; James, A.E. Paramagnetic agents for contrast-enhanced NMR imaging: A review. AJR Am. J. Roentgenol. 1983, 141, 1209-1215. [CrossRef] [PubMed]
2. Caravan, P. Strategies for increasing the sensitivity of gadolinium based MRI contrast agents. Chem. Soc. Rev. 2006, 35, 512-523. [CrossRef] [PubMed]
3. Edelman, R.R.; Warach, S. Magnetic resonance imaging (1). N. Engl. J. Med. 1993, 328, 708-716. [CrossRef] [PubMed]
4. Mitchell, D.G.; Cohen, M.S.; Saunders, W.B. MRI Principles; Saunders: Philadelphia, PA, USA, 2004; p. 416.
5. Lipinski, M.J.; Briley-Saebo, K.C.; Mani, V.; Fayad, Z.A. “Positive contrast” inversion-recovery with oxide nanoparticles-resonant water suppression magnetic resonance imaging. JAAC 2008, 52, 492-494. [CrossRef] [PubMed]
6. Hahn, P.F.; Stark, D.D.; Lewis, J.M.; Saini, S.; Elizondo, G.; Weissleder, R.; Fretz, C.J.; Ferrucci, J.T. First clinical trial of a new superparamagnetic iron oxide for use as an oral gastrointestinal contrast agent in MR imaging. Radiology 1990, 175, 695-700. [CrossRef] [PubMed]
7. Haegele, J.; Duschka, R.L.; Graeser, M.; Schaecke, C.; Panagiotopoulos, N.; Lüdtke-Buzug, K.; Buzug, T.M.; Barkhausen, J.; Vogt, F.M. Magnetic particle imaging: Kinetics of the intravascular signal in vivo. Int. J. Nanomedicine 2014, 9, 4203-4209. [CrossRef] [PubMed]
8. Stephen, Z.R.; Kievit, F.M.; Zhang, M. Magnetite nanoparticles for medical MR imaging. Mater. Today (Kidlington) 2011, 14, 330-338. [CrossRef]
9. Mendonca Dias, M.H.; Lauterbur, P.C. Ferromagnetic particles as contrast agents for magnetic resonance imaging of liver and spleen. Magn. Reson. Med. 1986, 3, 328-330. [CrossRef] [PubMed]
10. Colombo, M.; Carregal-Romero, S.; Casula, M.F.; Gutiérrez, L.; Morales, M.P.; Böhm, I.B.; Heverhagen, J.T.; Prosperi, D.; Parak, W.J. Biological applications of magnetic nanoparticles. Chem. Soc. Rev. 2012, 41, 4306-4334. [CrossRef] [PubMed]
11. Revia, R.A.; Zhang, M. Magnetite nanoparticles for cancer diagnosis, treatment, and treatment monitoring: Recent advances. Mater. Today 2016, 19, 157-168. [CrossRef]
12. Tromsdorf, U.I.; Bruns, O.T.; Salmen, S.C.; Beisiegel, U.; Weller, H. A highly effective, nontoxic T1 MR contrast agent based on ultrasmall PEGylated iron oxide nanoparticles. Nano Lett. 2009, 9, 4434-4440. [CrossRef] [PubMed]
13. Taboada, E.; Rodríguez, A.; Roig, J.; Oro, A.; Roch, R.; Muller, R.N. Relaxometric and magnetic characterization of ultrasmall iron oxide nanoparticles with high magnetization. Evaluation as potential T1 magnetic resonance imaging contrast agents for molecular imaging. Langmuir 2007, 23, 4583-4588. [CrossRef] [PubMed]
14. Bartolini, M.E.; Pekar, J.; Chettle, D.R.; McNeill, F.; Scott, A.; Sykes, J.; Prato, F.S.; Moran, G.R. An investigation of the toxicity of gadolinium based MRI contrast agents using neutron activation analysis. Magn. Reson. Imaging 2003, 21, 541-544. [CrossRef]
15. Perazella, M.A. Gadolinium-contrast toxicity in patients with kidney disease: Nephrotoxicity and nephrogenic systemic fibrosis. Curr. Drug Saf. 2008, 3, 67-75. [CrossRef] [PubMed]
16. Karlsson, H.L.; Cronholm, P.; Gustafsson, J.; Möller, L. Copper oxide nanoparticles are highly toxic: A comparison between metal oxide nanoparticles and carbon nanotubes. Chem. Res. Toxicol. 2008, 21, 1726-1732. [CrossRef] [PubMed]
17. Mahmoudi, M.; Simchi, A.; Milani, A.S.; Stroeve, P. Cell toxicity of superparamagnetic iron oxide nanoparticles. J. Colloid Interface Sci. 2009, 336, 510-518. [CrossRef] [PubMed]
18. Kodama, R.H.; Berkowitz, A.E. Atomic-scale magnetic modeling of oxide nanoparticles. Phys. Rev. B 1999, 59, 6321-6336. [CrossRef]
19. Swanson, S.D.; Kukowska-Latallo, J.F.; Patri, A.K.; Chen, C.; Ge, S.; Cao, Z.; Kotlyar, A.; East, A.T.; Baker, J.R. Targeted gadolinium-loaded dendrimer nanoparticles for tumor-specific magnetic resonance contrast enhancement. Int. J. Nanomed. 2008, 3, 201-210.
20. Morteza Mahmoudi, A.S. Superparamagnetic Iron Oxide Nanoparticles with Rigid Cross-linked polyethylene glycol fumarate coating for application in imaging and drug delivery. J. Phys. Chem. C 2009, 113, 8124-8131. [CrossRef]
21. Laurent, S.; Forge, D.; Port, M.; Roch, A.; Robic, C.; Vander Elst, L.; Muller, R.N. Magnetic iron oxide nanoparticles: Synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem. Rev. 2008, 108, 2064-2110. [CrossRef] [PubMed]
22. Lima-Tenório, M.K.; Pineda, E.A.G.; Ahmad, N.M.; Fessi, H.; Elaissari, A. Magnetic nanoparticles: In vivo cancer diagnosis and therapy. Int. J. Pharm. 2015, 493, 313-327. [CrossRef] [PubMed]
23. Kowalczyk, M.; Banach, M.; Rysz, J. Ferumoxytol: A new era of iron deficiency anemia treatment for patients with chronic kidney disease. J. Nephrol. 2011, 24, 717-722. [CrossRef] [PubMed]
24. Mahmoudi, M.; Hosseinkhani, H.; Hosseinkhani, M.; Boutry, S.; Simchi, A.; Journeay, W.S.; Subramani, K.; Laurent, S. Magnetic resonance imaging tracking of stem cells in vivo using iron oxide nanoparticles as a tool for the advancement of clinical regenerative medicine. Chem. Rev. 2011, 111, 253-280. [CrossRef] [PubMed]
25. McColgan, P.; Sharma, P.; Bentley, P. Stem cell tracking in human trials: A meta-regression. Stem Cell. Rev. 2011, 7, 1031-1040. [CrossRef] [PubMed]
26. Park, K. Facing the truth about nanotechnology in drug delivery. ACS Nano 2013, 7, 7442-7447. [CrossRef] [PubMed]
27. Venditto, V.; Szoka, F.C., Jr. Cancer Nanomedicines: So Many Papers and So Few Drugs! Adv. Drug. Deliv. Rev. 2013, 65, 80-88. [CrossRef] [PubMed]
28. Jin, R.; Lin, B.; Li, D.; Ai, H. Super paramagnetic iron oxide nanoparticles for MR imaging and therapy: Design considerations and clinical applications. Curr. Opin. Pharmacol. 2014, 18, 18-27. [CrossRef] [PubMed]
29. Lodhia, J.; Mandarano, G.; Ferris, N.; Eu, P.; Cowell, S. Development and use of iron oxide nanoparticles (Part 1): Synthesis of iron oxide nanoparticles for MRI. Biomed. Imaging Interv. J. 2010, 6, e12. [CrossRef] [PubMed]
30. Wang, J.; Chen, Y.; Chen, B.; Ding, J.; Xia, G.; Gao, C.; Cheng, J.; Jin, N.; Zhou, Y.; Li, X. et al. Pharmacokinetic parameters and tissue distribution of magnetic Fe3O4 nanoparticles in mice. Int. J. Nanomed. 2010, 5, 861-866.
31. Müller, R.H.; Jacobs, C. Buparvaquone mucoadhesive nanosuspension: Preparation, optimisation and long-term stability. Int. J. Pharm. 2002, 237, 151-161. [CrossRef]
32. Damalakiene, L.; Karabanovas, V.; Bagdonas, S.; Valius, M.; Rotomskis, R. Intracellular distribution of nontargeted quantum dots after natural uptake and microinjection. Int. J. Nanomed. 2013, 8, 555-568. [CrossRef] [PubMed]
33. Marmorato, P.; Ceccone, G.; Gianoncelli, A.; Pascolo, L.; Ponti, J.; Rossi, F.; Salomé, M.; Kaulich, B.; Kiskinova, M. Cellular distribution and degradation of cobalt ferrite nanoparticles in Balb/3T3 mouse fibroblasts. Toxicol. Lett. 2011, 207, 128-136. [CrossRef] [PubMed]
34. Sadeghiani, N.; Barbosa, L.S.; Silva, L.P.; Azevedo, R.B.; Morais, P.C.; Lacava, Z.G.M. Genotoxicity and inflammatory investigation in mice treated with magnetite nanoparticles surface coated with polyaspartic acid. J. Magn. Magn. Mater. 2005, 289, 466-468. [CrossRef]
35. Neuwelt, A.; Sidhu, N.; Hu, C.-A.A.; Mlady, G.; Eberhardt, S.C.; Sillerud, L.O. iron-based superparamagnetic nanoparticle contrast agents for MRI of infection and inflammation. AJR Am. J. Roentgenol. 2015, 204, W302-W313. [CrossRef] [PubMed]
36. Scudiero, D.A.; Shoemaker, R.H.; Paull, K.D.; Monks, A.; Tierney, S.; Nofziger, T.H.; Currens, M.J.; Seniff, D.; Boyd, M.R. Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res. 1988, 48, 4827-4833. [PubMed]
37. Zhu, X.-M.; Wang, Y.-X.J.; Leung, K.C.-F.; Lee, S. F.; Zhao, F.; Wang, D.-W.; Lai, J.M.Y.; Wan, C.; Cheng, C.H.K.; Ahuja, A.T. Enhanced cellular uptake of aminosilane-coated superparamagnetic iron oxide nanoparticles in mammalian cell lines. Int. J. Nanomed. 2012, 7, 953-964.
38. Hsu, S.; Ho, T.-T.; Tseng, T.-C. Nanoparticle uptake and gene transfer efficiency for MSCs on chitosan and chitosan-hyaluronan substrates. Biomaterials 2012, 33, 3639-3650. [CrossRef] [PubMed]
39. Dai, L.; Liu, Y.; Wang, Z.; Guo, F.; Shi, D.; Zhang, B. One-pot facile synthesis of PEGylated superparamagnetic iron oxide nanoparticles for MRI contrast enhancement. Mater. Sci. Eng. C 2014, 41, 161-167. [CrossRef] [PubMed]
40. Lee, C.-M.; Jeong, H.-J.; Kim, E.-M.; Kim, D.W.; Lim, S.T.; Kim, H.T.; Park, I.-K.; Jeong, Y.Y.; Kim, J.W.; Sohn, M.-H. Superparamagnetic iron oxide nanoparticles as a dual imaging probe for targeting hepatocytes in vivo. Magn. Reson. Med. 2009, 62, 1440-1446. [CrossRef] [PubMed]